Does PEGFILGRASTIM-CBQV Cause Hospitalisation? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Hospitalisation have been filed in association with PEGFILGRASTIM-CBQV. This represents 1.9% of all adverse event reports for PEGFILGRASTIM-CBQV.
14
Reports of Hospitalisation with PEGFILGRASTIM-CBQV
1.9%
of all PEGFILGRASTIM-CBQV reports
1
Deaths
13
Hospitalizations
How Dangerous Is Hospitalisation From PEGFILGRASTIM-CBQV?
Of the 14 reports, 1 (7.1%) resulted in death, 13 (92.9%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGFILGRASTIM-CBQV. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does PEGFILGRASTIM-CBQV Cause?
Device malfunction (356)
No adverse event (265)
Death (76)
Product dose omission issue (61)
Product label confusion (36)
Accidental exposure to product (29)
Neutrophil count decreased (18)
Bone pain (17)
Device failure (16)
Product packaging confusion (16)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which PEGFILGRASTIM-CBQV Alternatives Have Lower Hospitalisation Risk?
PEGFILGRASTIM-CBQV vs PEGFILGRASTIM-JMDB
PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA
PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2A
PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B
PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B OR PEGINTERFERON BETA-1A OR PEGINTERFERON LAMBDA-1A